Literature DB >> 4201308

Toxicology and pharmacology of the nitrosoureas.

V T Oliverio.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4201308

Source DB:  PubMed          Journal:  Cancer Chemother Rep 3        ISSN: 0069-0139


× No keyword cloud information.
  7 in total

1.  Nephrotoxicity of lomustine. A case report and literature review.

Authors:  M E Ellis; R B Weiss; M Kuperminc
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

2.  Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat.

Authors:  R A Kramer; M G McMenamin; M R Boyd
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.

Authors:  B Drewinko; L Y Yang
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity. III. Ultrastructural characterization of bile duct injury.

Authors:  N W Kretschmer; P J Boor; R A el Azhary; A E Ahmed; E S Reynolds
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Retrospective evaluation of nimustine use in the treatment of feline lymphoma.

Authors:  Kosei Sakai; Shingo Hatoya; Masaru Furuya; Tomoyo Nabetani; Ryoji Kanegi; Shunsuke Shimamura; Hiroyuki Tani; Terumasa Shimada
Journal:  Vet Med Sci       Date:  2021-10-02

6.  In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.

Authors:  R T Mulcahy; D W Siemann; R M Sutherland
Journal:  Br J Cancer       Date:  1981-01       Impact factor: 7.640

7.  The binding of 14C labelled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) to macromolecules of sensitive and resistant tumours.

Authors:  T A Connors; J R Hare
Journal:  Br J Cancer       Date:  1974-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.